CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.42 -0.15 (-4.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

CollPlant Biotechnologies (CLGN) Return on Capital Employed [ROCE] (2018 - 2025)

Updated

CollPlant Biotechnologies' Return on Capital Employed [ROCE] came in at -52.50% for the quarter ended Dec 31, 2025, down 53.75 percentage points from 1.24% a year earlier and down 7.18 percentage points from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Return on Capital Employed [ROCE] (2018 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, CollPlant Biotechnologies' Return on Capital Employed [ROCE] was -95.09%, down 21.52 percentage points from the prior year.

  • Return on Capital Employed [ROCE] carries a five-year change of -19.52 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Return on Capital Employed [ROCE] was -73.57% in the year ended Dec 31, 2024 (-50.60 pp), -22.98% in the year ended Dec 31, 2023 (+18.33 pp), -41.31% in the year ended Dec 31, 2022 (-41.54 pp) and 0.23% in the year ended Dec 31, 2021 (+75.81 pp).
  • The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Return on Capital Employed [ROCE] since the quarter ended Dec 31, 2020.
  • Year-over-year, Return on Capital Employed [ROCE] increased in two of the last six quarters, with an average year-over-year change of -11.64 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in the quarter ended Jun 30, 2021 (a gain of 91.20 percentage points), and the weakest in the quarter ended Dec 31, 2025 (a drop of 53.75 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 CollPlant Biotechnologies 4.38 Mn -25.06 Mn -456,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -52.50%
Sep 30, 2025 -45.32%
Dec 31, 2024 1.24%
Sep 30, 2024 -4.08%
Jun 30, 2024 -3.71%
Mar 31, 2024 1.17%
Dec 31, 2023 -1.45%
Sep 30, 2023 -0.22%
Jun 30, 2023 0.14%
Mar 31, 2023 -28.99%
Dec 31, 2022 -26.52%
Sep 30, 2022 -21.64%
Jun 30, 2022 -16.55%
Mar 31, 2022 -13.08%
Dec 31, 2021 0.13%
Sep 30, 2021 2.23%
Jun 30, 2021 9.42%
Mar 31, 2021 20.20%
Dec 31, 2020 -66.49%
Sep 30, 2020 -61.65%
API Access

CollPlant Biotechnologies Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLGN&period=max&api_key=YOUR_API_KEY